Dr. Marcus Haley
PharmD, BCPS
Board-certified pharmacotherapy specialist; reviews compound mechanism, dosing, and supply-chain claims.
Who reviews the work.
Dr. Marcus Haley is a Board Certified Pharmacotherapy Specialist (BCPS) with fourteen years of hospital and ambulatory pharmacy practice. He completed his PharmD at the University of Washington School of Pharmacy and practiced at Harborview Medical Center before moving into pharmacotherapy consulting. His clinical interest covers the full pharmacology stack — receptor pharmacology, pharmacokinetics, drug interactions, and the regulatory pathways that gate research-peptide and compounded-medication availability. Dr. Haley reads every Pepvise review for mechanism accuracy, dose-range correctness, and regulatory-status currency. He is the reason the Pepvise database can credibly distinguish between an FDA-approved agent, a 503A compounded preparation, and a research-channel grey-market peptide — the legal and clinical implications of those three categories are the layer most consumer-review sites elide. He holds no consulting relationships with vendors and no equity in compounding pharmacies.
What Dr. reviews on this site.
- Research-peptide reviews (BPC-157, TB-500, GHK-Cu, MOTS-c, AOD-9604, CJC-1295, Ipamorelin, Tesamorelin, Sermorelin)
- Pharmacokinetic / mechanism dimensions across all reviews
- Compounding-pathway and 503A category distinctions in the regulatory-posture cells
- Vendor-trust and supply-integrity scoring